Adequate blood pressure control: perception and reality

Area of Science:

• Cardiology
• Pharmacology

Background:

• 24-hour blood pressure control is crucial for preventing cardiac events and mortality.
• Once-daily antihypertensive medication dosing often leads to inadequate control due to peak-dose titration.
• Angiotensin-converting enzyme (ACE) inhibitors have a concentration-response relationship impacting their 24-hour efficacy.

Purpose of the Study:

• To evaluate the effectiveness of once-daily ACE inhibitors for 24-hour blood pressure control.
• To determine optimal titration strategies considering drug pharmacokinetics and pharmacodynamics.
• To identify ACE inhibitors suitable for peak-dose titration to achieve sustained blood pressure management.

Main Methods:

• Analysis of ACE inhibitor pharmacokinetics and pharmacodynamics.
• Review of blood pressure monitoring data related to drug administration timing.
• Comparison of titration strategies based on peak versus trough blood pressure measurements.

Main Results:

• Short-acting ACE inhibitors may provide inadequate control when titrated based on peak blood pressure.
• ACE inhibitors with specific pharmacokinetic profiles, like perindopril (4 or 8 mg), can achieve 24-hour control even with peak-dose titration.
• A trough-to-peak (T:P) ratio near 1.0 is indicative of effective 24-hour blood pressure control.

Conclusions:

• Understanding drug pharmacokinetics and pharmacodynamics is key to optimizing once-daily antihypertensive therapy.
• Peak-dose titration can achieve sustained blood pressure control with appropriate ACE inhibitors and dosing.
• Individualized therapy considering drug properties and patient monitoring enables effective hypertension management.